MTOR and neoplasm: Additionally, compared to control group, the inhibition rate of tumor growth was 58.27% after mTOR siRNA alone treatment and 63.18% after single-agent cisplatin, respectively, while combination of mTOR siRNA with cisplatin significantly enhanced the inhibition effect of tumor growth with 76.70% on ESCC in vivo at termination of the experiment.